+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Teva Pharmaceutical Industries Ltd. - logo

Teva Pharmaceuticals develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. The company has a portfolio of more than 1,000 molecules, producing approximately 64 billion tablets and capsules a year at 66 manufacturing facilities. It currently ranks among the 10 top pharmaceutical companies in the world and is active in 60 countries. Founded in 1901, and based in Israel, Teva employs approximately 58,000 people around the world.

Facial Palsy - Global Strategic Business Report - Product Thumbnail Image

Facial Palsy - Global Strategic Business Report

  • Report
  • October 2026
  • 367 Pages
  • Global
From
Paresthesia Treatment - Global Strategic Business Report - Product Thumbnail Image

Paresthesia Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 381 Pages
  • Global
From
Parkinson's Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Parkinson's Disease Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 382 Pages
  • Global
From
Anticholinergic Drugs - Global Strategic Business Report - Product Thumbnail Image

Anticholinergic Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 276 Pages
  • Global
From
From
Migraine Drugs - Global Strategic Business Report - Product Thumbnail Image

Migraine Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 500 Pages
  • Global
From
From
From
Neurodegenerative Drugs - Global Strategic Business Report - Product Thumbnail Image

Neurodegenerative Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 376 Pages
  • Global
From
Multiple Sclerosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Multiple Sclerosis Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 235 Pages
  • Global
From
Blarcamesine - Global Strategic Business Report - Product Thumbnail Image

Blarcamesine - Global Strategic Business Report

  • Report
  • October 2026
  • 370 Pages
  • Global
From
Barbiturate Drugs - Global Strategic Business Report - Product Thumbnail Image

Barbiturate Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 386 Pages
  • Global
From
Delirium - Global Strategic Business Report - Product Thumbnail Image

Delirium - Global Strategic Business Report

  • Report
  • October 2026
  • 281 Pages
  • Global
From
From
From
From
From
Epilepsy Treatment - Global Strategic Business Report - Product Thumbnail Image

Epilepsy Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 483 Pages
  • Global
From
Levodopa - Global Strategic Business Report - Product Thumbnail Image

Levodopa - Global Strategic Business Report

  • Report
  • October 2026
  • 377 Pages
  • Global
From
Dystonia Drugs - Global Strategic Business Report - Product Thumbnail Image

Dystonia Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 369 Pages
  • Global
From
Loading Indicator